Becton, Dickinson & Co. (NYSE: BDX)

https://www.bd.com

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. *

	Start	1897-01-01 established
	Group	Becton, Dickinson (Group)
	Industry	laboratory equipment and instruments
	Industry 2	diagnostics (medical/biological)

	Street	1 Becton Drive
	City	07417 Franklin Lakes, NJ
		Address record changed: 2020-12-02

Basic data	Employees	H: 10,001 to 50,00 (2011-02-07)
	Currency	USD
	Annual sales	8,054,000,000 (revenues (2012/13) 2013-09-30)
	Profit	1,293,000,000 (2013-09-30)

		* Document for »About Section«:

		Record changed: 2024-10-04

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Becton, Dickinson (Group)

[1] Enable Medicine. (2/13/24). "Press Release: Enable Medicine Appoints Kamni Vijay as Chief Executive Officer". Menlo Park, CA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com